La taille du marché du diagnostic de transplantation a été estimée à 1 542,89 millions de dollars américains d'ici 2027, contre 789,88 millions de dollars américains en 2018 ; on estime qu'il augmentera à un TCAC de 7,9 % entre 2019 et 2027.
Le diagnostic de transplantation fait référence aux tests de diagnostic effectués sur les organes destinés à être transplantés. Ces tests sont effectués soit avant la transplantation, soit après la transplantation. Certaines des techniques courantes utilisées dans le diagnostic des transplantations sont les analyses moléculaires basées sur des séquences, les analyses moléculaires basées sur la PCR et les analyses non moléculaires dans certains cas. Le diagnostic de transplantation est un facteur essentiel dans la transplantation d'organes car il évite toute complication supplémentaire qui pourrait survenir après une procédure de transplantation.
La croissance du marché du diagnostic de transplantation est attribuée à la prévalence croissante des maladies cardiovasculaires. maladies et croissance significative de lindustrie de la biotechnologie. Cependant, les opérations coûteuses de transplantation d'organes peuvent entraver la croissance du marché.
Régions lucratives pour le marché des diagnostics de transplantation
Aperçu du marché
Prévalence croissante des maladies cardiovasculaires
Les maladies cardiovasculaires sont la principale cause de décès dans le monde. Le vieillissement de la population montre généralement une altération structurelle et fonctionnelle de l'accumulation de vaisseaux au cours de leur vie. Ainsi, cela augmente le risque de développer des maladies cardiovasculaires. Selon l'American College of Cardiology, il est indiqué que les maladies cardiovasculaires sont responsables de près de 800 000 décès aux États-Unis, soit environ un décès sur trois. La maladie coronarienne (CHD) contribue à la majorité des décès par maladies cardiovasculaires, suivie par les accidents vasculaires cérébraux et l'insuffisance cardiaque. Près de plus de 90 millions dAméricains reçoivent un diagnostic de maladie cardiovasculaire. En outre, il est indiqué qu'au niveau mondial, les maladies cardiovasculaires représentent environ 31 % de tous les décès et que le coût des maladies cardiovasculaires devrait atteindre environ 1 044 milliards de dollars d'ici 2030.
Les comptes des maladies cardiovasculaires pour 45,0% de tous les décès en Europe et 37,0% de tous les décès dans l'UE. Pour cette raison, le besoin de diagnostics de transplantation pour la transplantation d'organes est susceptible de propulser le marché au cours de la période de prévision.
Informations basées sur les produits et services
Le marché mondial du diagnostic de transplantation, basé sur sur les produits et services, est segmenté en instruments, réactifs et consommables, et logiciels et services. Le segment des réactifs et consommables était le segment le plus important parmi les sous-segments de produits et services sur le marché du diagnostic de transplantation en 2018. Cependant, le segment des logiciels et services devrait connaître une croissance de sa demande au TCAC le plus rapide de 9,6 % entre 2019 et 2027.
Informations basées sur les types
Le marché mondial du diagnostic de transplantation, en fonction du type, est segmenté en transplantation d'organes solides, en transplantation de tissus mous et en transplantation de cellules souches. Le segment de la transplantation d'organes solides détenait la plus grande part du marché du diagnostic de transplantation en 2018 et devrait continuer à détenir le plus grand marché au cours de la période de prévision.
Informations basées sur la technologie
Le Le marché mondial du diagnostic de transplantation, basé sur la technologie, est segmenté en tests moléculaires et tests non moléculaires. En 2018, le segment des systèmes d'analyses moléculaires détenait une part de marché plus importante et devrait connaître une croissance de sa demande à un TCAC plus rapide de 9,5 % entre 2019 et 2027.
Informations basées sur les applications
Le marché mondial du diagnostic de transplantation, en fonction des applications, est segmenté en applications de diagnostic et en applications de recherche. En 2018, le segment des applications de diagnostic détenait une part de marché plus importante et devrait croître à un rythme plus rapide au cours des années à venir.
Informations stratégiques
Les lancements et les approbations de produits sont généralement stratégies adoptées par les entreprises pour étendre leur empreinte mondiale et leur portefeuille de produits. De plus, les acteurs du marché du diagnostic de transplantation se concentrent sur la stratégie de partenariat pour élargir leur clientèle, ce qui, à son tour, leur permet de maintenir leur marque à travers le monde.
Profils d'entreprises
- BIOMÉRIEUX SA
- ILLUMINA, INC.
- THERMO FISHER SCIENTIFIC, INC.
- QIAGEN NV
- F. HOFFMANN-LA ROCHE LTÉE.
- HOLOGIC INC.
- LUMINEX CORPORATION
- OMIXON INC.
- ABBOTT
< li>BIO-RAD LABORATORIES, INC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Transplant diagnostics refers to the diagnostics tests that are conducted on the organs that are meant to be transplanted. These tests are performed pre and post transplantation.
Some of the common techniques used in transplant diagnostics include, sequence based molecular assays, and PCR based molecular assays and also non-molecular assays in certain cases.
The market is growing with CAGR of 7.9% from 2019-2027.
The major key players are Abbott, Illumina, Inc., Thermo Fisher Scientific Inc., QIAGEN, Omixon Inc., Hologic Inc., Luminex Corporation, F. Hoffmann-La Roche Ltd, bioMérieux SA.
- Thermo Fisher Scientific Inc.
- Abbott
- Illumina, Inc.
- F. Hoffmann-La Roche Ltd
- Bio-Rad Laboratories, Inc.
- bioMérieux SA
- QIAGEN
- Hologic Inc.
- Luminex Corporation
- Omixon Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Apr 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Apr 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Apr 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Apr 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Apr 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Apr 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)